Teva has been through a lot of bad news in the past few years. A bad CEO, a terrible aquisition, lots of debt and then the covid pandemic. i simply think they have been beaten down way too much. There's a new management team in place, debt has been restructured and Teva can get back to the business of selling generic drugs - and it's a good business which Teva does well. Down 55% in one month.. this is a great entry point in my opinion.